Balance Sheet for Sucampo Pharmaceuticals Inc. (SCMP)

$ N/A N/A (N/A) Volume: 0 N/A
Statement: View:
Assets [+] in Thousands of Dollars
12/2016 12/2015 12/2014 12/2013 12/2012
Cash and Equivalents 198,308 108,284 71,622 44,102 52,022
Restrictable Cash 213 55,218 213 26,115 15,113
Marketable Securities - 108,407 22,393 16,003 6,035
Accounts Receivable 42,998 22,759 5,338 5,407 1,360
Loans Receivable - - - - -
Other Receivables 26,261 22,792 18,576 14,829 14,907
Receivables 69,259 45,551 23,914 20,236 16,267
Inventories, Raw Materials 1,414 5,554 - - -
Inventories, Work in Progress 18,045 26,926 - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 4,009 641 - - -
Inventories, Other 23,468 33,121 - 209 -
Inventories, Adjustments & Allowances - - - - -
Inventories 23,468 33,121 - 209 -
Prepaid Expenses 15,967 8,891 3,411 3,987 1,930
Current Deferred Income Taxes - 2,568 1,047 2,028 874
Other Current Assets - - - - -
Total Current Assets 307,232 251,360 121,848 113,353 92,914
Land and Improvements - - - - -
Buildings and Improvement 4,234 4,088 1,415 1,444 1,478
Machinery, Furniture and Equipment 5,590 5,744 3,095 3,087 3,032
Construction in Progress 119 140 - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 9,943 9,972 4,510 4,531 4,510
Gross Fixed Assets 9,943 9,972 4,510 4,531 4,510
Accumulated Depreciation (3,727) (3,579) (3,747) (3,375) (2,970)
Net Fixed Assets 6,216 6,393 763 1,156 1,540
Intangibles 128,134 130,315 151 6,438 7,415
Cost in Excess 73,022 60,937 - - -
Non-Current Deferred Income Taxes - 5,813 571 1,212 1,654
Other Non-Current Assets 690 6,776 3,577 2,959 4,652
Total Non-Current Assets 213,619 205,821 19,726 23,524 34,882
Total Assets 520,851 457,181 141,574 136,877 127,796
Liabilities [+] in Thousands of Dollars
12/2016 12/2015 12/2014 12/2013 12/2012
Accounts Payable 9,190 11,213 4,143 7,614 5,496
Short Term Debt - - - - -
Notes Payable - 39,083 8,240 26,892 19,129
Accrued Expenses 12,389 10,886 8,467 5,682 10,595
Accrued Liabilities 12,389 10,886 8,467 5,682 10,595
Deferred Revenues 1,315 676 2,051 1,365 3,700
Current Deferred Income Taxes - - - (1,678) (23,026)
Other Current Liabilities 9,457 26,269 10,909 989 1,151
Total Current Liabilities 32,351 88,127 33,810 42,612 40,071
Long Term Debt 290,516 213,277 17,578 25,828 33,722
Deferred Income Tax 21,289 52,497 820 2,066 2,627
Other Non-Current Liabilities 9,596 16,831 7,054 7,402 8,346
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 321,401 282,605 25,452 35,296 44,695
Total Liabilities 353,752 370,732 59,262 77,908 84,766
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 167,099 86,449 82,312 58,969 43,030
Common Par 464 455 446 432 420
Additional Paid in Capital 120,251 99,212 83,646 72,109 62,521
Cumulative Translation Adjustments - - - - -
Retained Earnings 38,126 19,639 (13,732) (26,860) (34,100)
Treasury Stock 46,269 46,269 2,313 2,313 1,977
Other Equity Adjustments 54,527 13,412 14,265 15,601 16,166
Total Capitalization 457,615 299,726 99,890 84,797 76,752
Total Equity 167,099 86,449 82,312 58,969 43,030
Total Liabilities & Shareholder's Equity 520,851 457,181 141,574 136,877 127,796
Cash Flow 18,486 22,670 11,955 4,751 3,281
Working Capital 274,881 163,233 88,038 70,741 52,843
Free Cash Flow 7,087 13,148 30,812 (5,586) 8,561
Invested Capital 457,615 299,726 99,890 84,797 76,752
Shares Outstanding - Common Class Only 46,416 45,509 44,603 43,316 41,965
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 46,416 45,509 44,603 43,316 41,965
Total Common Shares Outstanding 46,416 45,509 44,603 43,316 41,965
Treasury Shares 3,010 3,010 525 525 457
Basic Weighted Shares Outstanding 42,791 44,150 43,691 41,716 41,660
Diluted Weighted Shares Outstanding 43,749 45,680 44,506 42,544 41,785